NASDAQ:ADXS Ayala Pharmaceuticals (ADXS) Stock Forecast, Price & News $0.85 -0.14 (-14.14%) (As of 05/26/2023 ET) Add Compare Share Share Today's Range$0.85▼$1.1850-Day Range N/A52-Week Range$0.65▼$7.20Volume15,594 shsAverage Volume9,756 shsMarket Capitalization$1.55 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsSocial MediaProfileChartCompetitorsSocial Media About Ayala PharmaceuticalsAdvaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ.Read More Receive ADXS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address ADXS Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive ADXS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address ADXS Company Calendar Today5/27/2023Fiscal Year End10/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:ADXS CUSIPN/A CIKN/A Webwww.ayalapharma.com Phone(609) 452-9813Fax609-452-9818EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($8.93) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,360,000.00 Net MarginsN/A Pretax Margin-578,049.94% Return on Equity-125.27% Return on Assets-89.23% Debt Debt-to-Equity RatioN/A Current Ratio1.86 Quick Ratio11.18 Sales & Book Value Annual Sales$250,000.00 Price / Sales6.19 Cash FlowN/A Price / Cash FlowN/A Book Value$5.33 per share Price / Book0.16Miscellaneous Outstanding Shares1,820,000Free Float1,810,000Market Cap$1.55 million OptionableNot Optionable Beta2.44 Key ExecutivesKen BerlinPresident, Chief Executive Officer & DirectorIgor GitelmanVP-Finance, Chief Financial & Accounting OfficerAndres A. GutiérrezChief Medical Officer & Executive Vice PresidentMichael GraceVice President-Technical OperationsKey CompetitorsAmpio PharmaceuticalsNYSE:AMPECan-Fite BioPharmaNYSE:CANFNovaBay PharmaceuticalsNYSE:NBYOragenicsNYSE:OGENAspira Women's HealthNYSE:AWHView All Competitors ADXS Stock - Frequently Asked Questions How have ADXS shares performed in 2023? Ayala Pharmaceuticals' stock was trading at $0.99 at the start of the year. Since then, ADXS shares have decreased by 14.1% and is now trading at $0.85. View the best growth stocks for 2023 here. What other stocks do shareholders of Ayala Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Ayala Pharmaceuticals investors own include Inovio Pharmaceuticals (INO), Madrigal Pharmaceuticals (MDGL), Merck & Co., Inc. (MRK), Anavex Life Sciences (AVXL), VistaGen Therapeutics (VTGN), Novavax (NVAX), Highpower International (HPJ), OPKO Health (OPK) and Athersys (ATHX). What is Ayala Pharmaceuticals' stock symbol? Ayala Pharmaceuticals trades on the NASDAQ under the ticker symbol "ADXS." How do I buy shares of Ayala Pharmaceuticals? Shares of ADXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Ayala Pharmaceuticals' stock price today? One share of ADXS stock can currently be purchased for approximately $0.85. How much money does Ayala Pharmaceuticals make? Ayala Pharmaceuticals (NASDAQ:ADXS) has a market capitalization of $1.55 million and generates $250,000.00 in revenue each year. The company earns $-14,360,000.00 in net income (profit) each year or ($8.93) on an earnings per share basis. How can I contact Ayala Pharmaceuticals? Ayala Pharmaceuticals' mailing address is 9 DEER PARK DRIVE SUITE K-1, MONMOUTH JUNCTION NJ, 08852. The official website for the company is www.ayalapharma.com. The company can be reached via phone at (609) 452-9813, via email at ir@ayalapharma.com, or via fax at 609-452-9818. This page (NASDAQ:ADXS) was last updated on 5/27/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ayala Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.